Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional Hemosiderosis

NCT00631163 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

102

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Anemia
Transfusional Hemosiderosis

Interventions

DRUG: Deferasirox (ICL670)

Sponsor

Novartis Pharmaceuticals